Additional value of the 70-gene signature and levels of ER and PR for the prediction of outcome in tamoxifen-treated ER-positive breast cancer. The breast, Dec. 2012, Vol. 21(6), p.769-78.
Kok, M., et al.
http://www.thebreastonline.com/article/PIIS0960977612000823/abstract?rss=yes
Breast cancer patients with node positive disease can have an excellent outcome with tamoxifen only. It is unclear whether analysing both the 70-gene signature and hormone receptors provides superior prediction of outcome in tamoxifen-treated patients than either alone.
